Novartis Uses US Bond Issue To Expand RNA And Peptide Pipeline
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
Starpharma Announces a Collaboration and License Agreement
MELBOURNE, Australia, Sept. 22, 2025 (GLOBE NEWSWIRE) — Starpharma (ASX: SPL, US OTC: SPHRY), an innovative Australian biotechnology…
Novartis enters licensing agreement with UNP for peptide therapeutics
Novartis has signed a research partnership and licensing agreement with Unnatural Products (UNP) valued at up to $1.7bn…
Unnatural Products, Novartis sign licensing agreement for cardiovascular program
Wed, February 18, 2026 at 1:35 PM UTC A sign marks the Novartis Institutes for BioMedical Research facility…
Unnatural Products and Novartis Sign Heart Therapy
Editorial & Advertiser disclosure Global Banking & Finance Review® is an online platform offering news, analysis, and opinion…